Trial · NCT03314935
Participant flow90
How many started, completed or left each group, period by period.
1 to 20 of 90
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Phase 1 | STARTED | Phase 1: INCB001158 50 mg + mFOLFOX6 | 8 | |
| Phase 1 | STARTED | Phase 1: INCB001158 75 mg + mFOLFOX6 | 6 | |
| Phase 1 | STARTED | Phase 1: INCB001158 100 mg + mFOLFOX6 | 6 | |
| Phase 1 | STARTED | Phase 1: INCB001158 50 mg + Gemcitabine + Cisplatin | 7 | |
| Phase 1 | STARTED | Phase 1: INCB001158 75 mg + Gemcitabine + Cisplatin | 4 | |
| Phase 1 | STARTED | Phase 1: INCB001158 100 mg + Gemcitabine + Cisplatin | 4 | |
| Phase 1 | STARTED | Phase 1: INCB001158 50 mg + Paclitaxel | 7 | |
| Phase 1 | STARTED | Phase 1: INCB001158 75 mg + Paclitaxel | 5 | |
| Phase 1 | STARTED | Phase 1: INCB001158 100 mg + Paclitaxel | 7 | |
| Phase 1 | STARTED | Phase 2: INCB001158 100 mg + mFOLFOX6: MSS-CRC (Cohort A1) | 0 | |
| Phase 1 | STARTED | Phase 2: INCB001158 100 mg + Gemcitabine + Cisplatin: BTC (Cohort B1) | 0 | |
| Phase 1 | STARTED | Phase 2: INCB001158 100 mg + Gemcitabine + Cisplatin: OC (Cohort B2) | 0 | |
| Phase 1 | STARTED | Phase 2: INCB001158 100 mg + Paclitaxel: GC (Cohort C1) | 0 | |
| Phase 1 | STARTED | Phase 2: INCB001158 100 mg + Paclitaxel: EC (Cohort C2) | 0 | |
| Phase 1 | STARTED | Phase 2: INCB001158 100 mg + Paclitaxel: OC (Cohort C3) | 0 | |
| Phase 1 | COMPLETED | Phase 1: INCB001158 50 mg + mFOLFOX6 | 0 | |
| Phase 1 | COMPLETED | Phase 1: INCB001158 75 mg + mFOLFOX6 | 0 | |
| Phase 1 | COMPLETED | Phase 1: INCB001158 100 mg + mFOLFOX6 | 0 | |
| Phase 1 | COMPLETED | Phase 1: INCB001158 50 mg + Gemcitabine + Cisplatin | 0 | |
| Phase 1 | COMPLETED | Phase 1: INCB001158 75 mg + Gemcitabine + Cisplatin | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03314935/flow